ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.82 (3.06%)
Dec 26, 2024, 12:22 PM EST - Market open
ArriVent BioPharma Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$36.80
Upside
+34.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +31.17% | Nov 15, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +31.17% | Sep 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +42.10% | Sep 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $38 | Strong Buy | Maintains | $28 → $38 | +38.46% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +31.17% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +9.31% | Aug 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 | Buy | Reiterates | $35 | +27.53% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | -8.91% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | -8.91% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | -8.91% | Apr 30, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +9.31% | Feb 20, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +27.53% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | -1.62% | Feb 20, 2024 |